What is Strides Pharma Science Ltd. Quarterly Revenue?

Strides Pharma Science Ltd. Quarterly Revenue Strides Pharma Jun-2026 Quarterly Revenue is Rs 584 Cr which is growth of 16.7% YoY.

What is Strides Pharma Science Ltd. Quarterly Net Profit?

Strides Pharma Science Ltd. Quarterly Net Profit Strides Pharma Jun-2026 Quarterly Net Profit is Rs 73 Cr which is growth of 446.4% YoY.

What is Strides Pharma Science Ltd. Annual Revenue?

Strides Pharma Science Ltd. Annual Revenue Strides Pharma Mar-2026 Annual Revenue is Rs 2,303 Cr which is growth of 5.4% YoY.

What is Strides Pharma Science Ltd. Annual Net Profit?

Strides Pharma Science Ltd. Annual Net Profit Strides Pharma Mar-2026 Annual Net Profit is Rs 184 Cr which is growth of -93.6% YoY.

What is Strides Pharma Science Ltd. Total Shareholders Fund?

Strides Pharma Science Ltd. Total Shareholders Fund Strides Pharma Mar-2026 Total Shareholders Fund is Rs 3,284 Cr which is growth of 2.8% YoY.

What is Strides Pharma Science Ltd. Total Assets?

Strides Pharma Science Ltd. Total Assets Strides Pharma Mar-2026 Total Assets is Rs 5,396 Cr which is growth of 7.3% YoY.

What is Strides Pharma Science Ltd. Book Value Per Share?

Strides Pharma Science Ltd. Book Value Per Share Strides Pharma Mar-2026 Book Value Per Share is 356 Rs which is growth of 2.8% YoY.

What is Strides Pharma Science Ltd. ROE?

Strides Pharma Science Ltd. ROE Strides Pharma Mar-2026 ROE is 6% which is growth of 84.8% YoY.

What is Strides Pharma Science Ltd. Cash From Operating Activity?

Strides Pharma Science Ltd. Cash From Operating Activity Strides Pharma Mar-2026 Cash From Operating Activity is Rs 278 Cr which is growth of -34.1% YoY.

What is Strides Pharma Science Ltd. Net Cash Flow?

Strides Pharma Science Ltd. Net Cash Flow Strides Pharma Mar-2026 Net Cash Flow is Rs 10 Cr which is growth of 111.4% YoY.

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531

Strong Performer, Under Radar

Download real time

-10.00(-0.91%)

41.20% Gain from 52W Low

198.7K

NSE+BSE Volume

NSE 09 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Strides Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Strides Pharma share price target, revenues, EPS, net income and more

Strides Pharma quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Strides Pharma Jun-2026 Quarterly Revenue is Rs 584 Cr which is growth of 16.7% YoY.
POSITIVE
Quarterly Net Profit Strides Pharma Jun-2026 Quarterly Net Profit is Rs 73 Cr which is growth of 446.4% YoY.

Strides Pharma Science Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	584.1	609.7	656.9	536.2	500.4	568.1	553.3	633.5	566.6	647.3	528.7	562.6	487
SR_Q Operating Rev.	582.7	605.7	553.6	522.2	498.6	556	550.9	610	554.8	617.6	520	540.3	475.3
OI_Q Other Income	1.5	4	103.2	14.1	1.8	12.1	2.4	23.6	11.8	29.6	8.7	22.3	11.7
OEXPNS_Q Operating Exp.	521.5	531.3	472.4	459.9	431.4	488	476.8	546.9	493.7	526.8	454.4	497	419.8
OEXPNS_Q Operating Exp.	521.5	531.3	472.4	459.9	431.4	488	476.8	546.9	493.7	526.8	454.4	497	419.8
OP_Q Operating Profit	61.1	74.4	81.2	62.2	67.2	67.9	74.1	63	61	90.8	65.7	43.3	55.6
OPMPCT_Q Operating Profit Margin %	10.49%	12.28%	14.67%	11.92%	13.48%	12.22%	13.45%	10.33%	11.00%	14.70%	12.63%	8.01%	11.69%
DEP_Q Depr.	25.7	25.2	22.4	21.5	22.1	22.4	20.9	22	20.3	20.8	21.1	21.3	21.5
INT_Q Interest	28.5	26.7	27.2	29.4	30.5	29.4	34.2	50.2	46.9	46.8	44.5	40.1	36.6
PBT_Q Profit Before Tax	84.8	26.5	134.8	25.4	16.4	28.3	21.4	14.4	5.7	52.8	3.5	4.2	9.1
TAX_Q Tax	11.8	10.2	12.9	-6.7	3.1	12.2	6.4	-0.9	1.7	-0.9	1	2.9	1.1
NP_Q Net Profit	72.9	16.4	121.9	32	13.4	16.1	14.9	15.3	3.9	53.7	2.5	1.3	8
EPS_adj_Q EPS Adj. latest	7.9	1.8	13.2	3.5	1.5	1.8	1.6	1.7	0.4	5.8	0.3	0.1	0.9
NP_TTM Net profit TTM	243.2	183.6	183.4	76.5	59.7	50.3	87.8	75.4	61.4	65.5	74.2	84.2	78.9
EPS_TTM Basic EPS TTM	26.4	19.9	19.9	8.3	6.5	5.5	9.5	8.2	6.7	7.1	8.1	9.3	8.7
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Strides Pharma competitor comparison and performance snapshot within industry

Strides Pharma revenue mix: sales, profit, and capital employed breakups by segment

Strides Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Strides Pharma Mar-2026 Annual Revenue is Rs 2,303 Cr which is growth of 5.4% YoY.
NEGATIVE
Annual Net Profit Strides Pharma Mar-2026 Annual Net Profit is Rs 184 Cr which is growth of -93.6% YoY.

Strides Pharma Science Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	5.9%	3.4%	2,386.9	2,303.2	2,185.6	2,225.6	1,938.6	2,102.5	1,946.6	1,774.3	1,652	1,625.8	1,550.9	2,344.5
TotalOperatingRevenues_A Operating Rev. Ann.	5.5%	3.3%	2,264.2	2,180.1	2,139.4	2,153.3	1,854.5	1,979	1,857.6	1,674.2	1,537.4	1,469.6	1,381.8	2,203.5
OI_A Other Income Ann.	13.5%	6.7%	122.8	123.1	46.2	72.3	84.1	123.5	89	100.2	114.6	156.2	169.1	141
OEXPNS_A Operating Exp. Ann.	2.6%	2.6%	1,985.2	1,895.1	1,877	1,898	1,756	1,902.4	1,670.3	1,464.1	1,398.4	1,272.5	1,211.1	1,921.4
OEXPNS_A Operating Exp. Ann.	2.6%	2.6%	1,985.2	1,895.1	1,877	1,898	1,756	1,902.4	1,670.3	1,464.1	1,398.4	1,272.5	1,211.1	1,921.4
OP_A Operating Profit Ann.	42.5%	8.8%	278.9	285	262.4	255.3	98.5	76.6	187.3	210	139	197.1	170.7	282.1
OPMPCT_A OPM Ann. %	34.6%	5.2%		12.38%	12.01%	11.47%	5.08%	3.64%	9.62%	11.84%	8.42%	12.12%	11.01%	12.03%
TotalExpenses_A Total Exp. Ann. ⌄	1.8%	2.7%		2,100.1	2,107.5	2,150.6	1,988.3	2,081	1,834.9	1,622.5	1,535.5	1,432.3	1,353.1	2,130
OtherExpenses_A Other Exp. Ann.	-1.6%	-0.3%	423.2	403.5	415.9	456.3	423.4	528.8	408.7	354.4	296.4	266.7	248.2	391.7
EmployeeBenefitExpenses_A Employee Exp. Ann.	12.6%	7%	390	381.6	377.6	335.2	267	272.1	272.7	221.8	223.2	224.5	228.5	275
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	30.8%	8.1%		408.1	308.6	327.6	182.5	200.1	276.3	310.2	253.7	353.3	339.8	423
EBIDTPCT_A EBITDA Ann. margin %	23.4%	4.5%		17.72%	14.12%	14.72%	9.42%	9.52%	14.20%	17.48%	15.35%	21.73%	21.91%	18.04%
INT_A Interest Ann.	-6.4%	11.7%	111.8	113.8	145.9	167.9	138.7	74.2	65.3	66.7	54.1	82	72	102.7
DEP_A Depr.	-0.9%	-1.7%	94.8	91.2	84.6	84.7	93.6	104.4	99.3	91.6	83	77.8	70	105.9
PBT_A PBT Ann.	-	12.7%	271.5	203.1	78.1	69.6	-64.8	21.5	111.6	151.9	113	164.1	182.7	189.3
TAX_A Tax Ann.	-	-10.2%	28.2	19.5	18.9	4.1	-69.4	-158.7	33.4	40.2	-1.4	7.7	30.7	28.2
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	239.3%	18.6%		183.6	59.2	65.5	4.7	180.2	78.2	111.7	114.4	156.5	151.9	161.1
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	239.3%	18.6%	243.2	183.6	2,886.2	65.5	4.7	180.2	78.2	111.7	110.4	891.6	108.5	161.1
NETPCT_A NPM Ann. %	222.9%	14.9%		8.42%	134.90%	3.04%	0.25%	9.10%	4.21%	6.67%	7.17%	60.66%	7.85%	7.30%
EPS_adj_A EPS Adj. latest Ann.	241.4%	18.5%		19.9	313.1	7.1	0.5	19.6	8.5	12.1	12	96.7	11.8	17.5
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

5.4%

2Y CAGR

1.7%

3Y CAGR

5.9%

5Y CAGR

3.4%

7Y CAGR

4.9%

10Y CAGR

-0.2%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

-93.6%

2Y CAGR

67.4%

3Y CAGR

239.3%

5Y CAGR

18.6%

7Y CAGR

7.5%

10Y CAGR

1.3%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

2Y CAGR

-0.1%

3Y CAGR

2.6%

5Y CAGR

2.6%

7Y CAGR

4.4%

10Y CAGR

-0.1%

Operating Expenses Annual Cr growth is lower than historical averages.

Strides Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Strides Pharma Mar-2026 Total Shareholders Fund is Rs 3,284 Cr which is growth of 2.8% YoY.
POSITIVE
Total Assets Strides Pharma Mar-2026 Total Assets is Rs 5,396 Cr which is growth of 7.3% YoY.

Strides Pharma Science Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-1.7%	0.2%	3,283.5	3,192.7	3,561.1	3,455.1	3,406.3	3,248.1	3,175.2	3,256.8	3,161.9	3,232.5	3,135.4
EQCAP_A Equity Share Capital Ann.	0.7%	0.6%	92.2	92.2	91.9	90.3	89.8	89.7	89.6	89.6	89.5	89.4	89.4
TotalShareCapital_A Total Share Capital Ann.	0.7%	0.6%	92.2	92.2	91.9	90.3	89.8	89.7	89.6	89.6	89.5	89.4	89.4
ReservesAndSurplus_A Reserves Plus Surplus Ann.	-1.7%	0.2%	3,191.3	3,100.6	3,466.3	3,362.4	3,314.4	3,153.7	3,079.9	3,159.7	3,072.4	3,143.1	3,046.1
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	-1.7%	0.2%	3,191.3	3,100.6	3,466.3	3,362.4	3,314.4	3,153.7	3,079.9	3,159.7	3,072.4	3,143.1	3,046.1
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-9.6%	-6.6%	272.1	208.6	281.4	367.9	185.9	382.6	62.3	17	19.1	814.6	939.5
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-											33.6
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-3.5%	-26.4%	44.7	29.6	40.5	49.8	27.7	207	42.6	4	3.3	22.5	15
CL_A Total Current Liabilities Ann. ⌄	0.8%	3%	1,840.1	1,629.6	1,995.3	1,796.8	1,841.3	1,590.6	1,437.8	1,389	1,104.1	1,434.2	1,289.1
TradePayables_A Trade Payables Ann.	2.1%	-2%	685.6	484.9	504.2	643.4	643.8	756.7	474.1	509.4	390.7	470.6	497.2
OtherCurrentLiabilities_A Other Current Liabilities Ann.	28.6%	6%	157.3	92.8	75.7	73.9	57.1	117.8	92.4	49.5	84.9	290.3	195.7
ShortTermProvisions_A ST Provisions Ann.	14.1%	-0.4%	22.3	23.1	18.3	15	20.5	22.7	18.8	21.3	26.8	25.9	51.9
TL_A Total Capital Plus Liabilities Ann.	-1.3%	0.7%	5,395.7	5,030.9	5,837.8	5,619.7	5,433.9	5,221.3	4,675.3	4,662.8	4,285.2	5,481.2	5,364
FixedAssets_A Fixed Assets Ann. ⌄	14%	5%	966.1	872.6	650.2	651.9	672.6	755.2	724.5	696.1	707.8	1,351.6	1,238.9
TangibleAssets_A Tangible Assets Ann.	4.5%	3.4%	634.2	606.4	507.9	555.7	568	536.1	493.5	444.6	432.5	837.9	781.7
IntangibleAssets_A Intangible Assets Ann.	74%	30%	150.6	149.6	36.7	28.6	36.1	40.6	49.8	52.1	65.5	285.9	277.1
CapitalWorkInProgress_A Capital Work In Progress Ann.	74.5%	0.6%	84	65.7	57.7	15.8	30.5	81.4	86	72.6	86.9	99.6	126.4
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-4.7%	-2.8%	3,022.1	2,885.4	3,421.9	3,493.3	3,458.6	3,477.5	3,218.5	2,999.2	2,785.6	2,902.1	2,705
NonCurrentInvestments_A Non Current Investments Ann.	-9.2%	-4.8%	1,868.3	1,847.7	2,498.3	2,491.8	2,399.8	2,394.7	2,170.6	1,994.6	1,465.2	1,240.7	1,233.9
DeferredTaxAssets_A Deferred Tax Assets Ann.	6.2%	8.7%	114.1	100.2	91.5	95.2	77.6	75.2	81	80.1	53.5	19.3
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-			35	50.5	124.6	106.7	96.1	91.6	37.5	54.8	230.3
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-28.8%	-12.8%	73.7	64.9	146.9	203.9	184	145.8	146.3	136.8	521.6	235.7	1.9
CA_A Total Current Assets Ann. ⌄	3.7%	6.4%	2,373.6	2,145.5	2,415.9	2,126.4	1,975.3	1,743.9	1,456.8	1,663.6	1,499.5	2,579.2	2,659
CurrentInvestments_A Current Investments Ann.	-	-								154.3	311.5	1,279.5	1,133
TradeReceivables_A Trade Receivables Ann.	5.2%	13.1%	1,521.3	1,452.9	1,508.5	1,307.8	1,296.3	821.7	661.5	582.6	449.4	540.7	702.3
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-21.9%	-11%	40.7	30.5	111.8	85.6	14.5	73	108.4	180.8	79.8	94.9	94.3
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-53.8%	15.2%	7.3	10.1	104.2	74.2	4.3	3.6	77.2	27.6	26.2	8.7	326.2
OtherCurrentAssets_A Other Current Assets Ann.	10.1%	7.4%	224.1	220.3	221.2	168.1	147.1	156.5	164.9	245	363.1	245.8	24
TA_A Total Assets Ann.	-1.3%	0.7%	5,395.7	5,030.9	5,837.8	5,619.7	5,433.9	5,221.3	4,675.3	4,662.8	4,285.2	5,481.2	5,364
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-20.4%	-30.2%	319	301.4	817	632.1	2,345.1	1,929.3	3,498.1	5,766.3	4,437.2	5,478.5	5,370.3
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.3
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	1,868.3	1,847.7							0.1	1,240.7	1,233.9
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-											1,133

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

7.3%

2Y CAGR

-3.9%

3Y CAGR

-1.3%

5Y CAGR

0.7%

7Y CAGR

2.1%

10Y CAGR

0.1%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

12.9%

2Y CAGR

-4%

3Y CAGR

0.8%

5Y CAGR

7Y CAGR

4.1%

10Y CAGR

3.6%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

2.8%

2Y CAGR

-4%

3Y CAGR

-1.7%

5Y CAGR

0.2%

7Y CAGR

0.1%

10Y CAGR

0.5%

Total ShareHolders Funds Annual growth is higher than historical averages.

Strides Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Strides Pharma Mar-2026 Book Value Per Share is 356 Rs which is growth of 2.8% YoY.
POSITIVE
ROE Strides Pharma Mar-2026 ROE is 6% which is growth of 84.8% YoY.

Strides Pharma Science Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	-2.4%	-0.3%	356.2	346.4	387.5	382.6	379.4	362.2	354.5	363.7	353.3	361.5	350.9
ROA_A RoA Ann. %	249%	17.9%	3.40%	57.36%	1.12%	0.08%	3.31%	1.49%	2.38%	2.36%	20.80%	1.98%	3.00%
ROE_A ROE Ann. %	250.3%	18.4%	5.59%	90.39%	1.83%	0.13%	5.28%	2.40%	3.51%	3.38%	28.19%	3.35%	5.13%
ROCE_A ROCE Ann. %	56.6%	12.8%	8.91%	6.58%	6.32%	2.32%	2.66%	4.87%	6.75%	5.21%	8.65%	6.66%	7.78%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	23.9%	4.7%	18.71%	14.42%	15.21%	9.84%	10.11%	14.87%	18.52%	16.49%	24.03%	24.58%	19.19%
PBITMargin_A EBIT Ann. Margin %	44.8%	8.8%	14.53%	10.47%	11.28%	4.79%	4.83%	9.52%	13.05%	11.09%	18.74%	19.52%	14.39%
PBTMargin_A PBT Ann. Margin %	-	9.2%	9.31%	3.64%	3.23%	-3.49%	1.08%	6.00%	9.07%	7.35%	11.16%	13.21%	8.59%
NETPCT_A NPM Ann. %	222.9%	14.9%	8.42%	134.90%	3.04%	0.25%	9.10%	4.21%	6.67%	7.17%	60.66%	7.85%	7.30%
ASETTO_A Asset Turnover Ann. %	10.1%	0%	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.3	0.3	0.3	0.6
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	2.7%	3.4%	1.3	1.3	1.2	1.2	1.1	1.1	1	1.2	1.4	1.8	2.1
QuickRatio_A Quick Ratio Ann.	3.6%	7.4%	1	1.1	1	0.9	0.8	0.7	0.7	0.9	1.1	1.5	1.8
DividendPayoutNP_A Dividend Payout to NP Ann.	-	0%	0.2	0.5	0.2		0.1	0.2	1.2	0.2	0.1	0.3	0.2
EarningRetention_A Earning Retention Ann. %	-	0.7%	79.93%	99.21%	79.32%			77.11%	-39.93%	83.78%	94.64%	60.18%	73.64%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-0.8%	86.59%	99.23%	90.98%			89.92%	23.13%	90.74%	95.07%	75.79%	84.10%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-0.8%	86.59%	99.23%	90.98%			89.92%	23.13%	90.74%	95.07%	75.79%	84.10%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	36.3%	3.2%	9,751	7,291.5	8,674.4	3,847.6	4,341.9	8,341.6	3,632.9	4,851.7	6,539.5	11,130.3	11,056.1
EVPerNetSales_A EV Per Net Sales Ann.	28.9%	0%	4.5	3.4	4	2.1	2.2	4.5	2.2	3.2	4.5	8.1	5
PBV_A Price To Book Value Adjusted	2.4%	0.3%	3.05	2.84	2.8	2.84	2.86	3	3.06	2.98	3.07	3	3.09
EVPerEBITDA_A EV Per EBITDA Ann.	4.2%	-4.6%	23.9	23.6	26.5	21.1	21.7	30.2	11.7	19.1	18.5	32.8	26.1
MarketCapPerSales_A Market Cap Per Sales Ann.	41.9%	-0.5%	4	2.9	3.3	1.4	1.6	4.1	1.7	2.8	4.1	7.1	4.4
RetentionRatios_A Retention Ratio Ann. %	-	0.7%	79.92%	99.20%	79.31%			77.10%	-39.93%	83.77%	94.63%	60.17%	73.63%
EYield_A Earnings Yield Ann.	-	-	0	0.5	0		0.1	0	0	0	0.2	0	0
DEBT_CE_A Total Debt to Total Equity Ann.	0%	5.9%	0.4	0.4	0.5	0.4	0.4	0.3	0.3	0.3	0.2	0.4	0.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-93.8%

2Y CAGR

74.8%

3Y CAGR

250.3%

5Y CAGR

18.4%

7Y CAGR

7.5%

10Y CAGR

0.9%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-94.1%

2Y CAGR

74.2%

3Y CAGR

249%

5Y CAGR

17.9%

7Y CAGR

5.4%

10Y CAGR

1.3%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

2Y CAGR

4.1%

3Y CAGR

2.7%

5Y CAGR

3.4%

7Y CAGR

1.2%

10Y CAGR

-4.7%

Current Ratio Annual is falling faster than historical averages.

Strides Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Strides Pharma Mar-2026 Cash From Operating Activity is Rs 278 Cr which is growth of -34.1% YoY.
POSITIVE
Net Cash Flow Strides Pharma Mar-2026 Net Cash Flow is Rs 10 Cr which is growth of 111.4% YoY.

Strides Pharma Science Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	4.7%	-0.4%	277.8	421.5	-35.8	241.7	-282.7	282.8	148.8	40	65.6	411.7	83.6
PBT_A PBT Ann.	-	12.7%	203.1	78.1	69.6	-64.8	21.5	111.6	151.9	113	164.1	182.7	189.3
INT_A Interest Ann.	-6.4%	11.7%	113.8	145.9	167.9	138.7	74.2	65.3	66.7	54.1	82	72	102.7
TAX_A Tax Ann.	-	-10.2%	19.5	18.9	4.1	-69.4	-158.7	33.4	40.2	-1.4	7.7	30.7	28.2
CFI_A Cash from Investing Act. Ann.	-	-	-69.1	-137.6	-61.3	-182.6	18.8	-275.6	50.9	-166.1	447.4	-344.1	-1,064.4
CFA_A Cash from Financing Act. Ann.	-	-	-198.9	-370.3	107.6	10.8	250.7	-48.6	-203.6	123.3	-706.8	-67.2	1,570.8
NCF_A Net Cash Flow Ann. ⌄	-48.1%	-	9.8	-86.4	10.6	70	-13.2	-41.5	-3.8	-2.8	-193.8	0.5	590
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-19.6%	-37.6%	6.3	92.8	82.1	12.1	25.3	66.8	69.5	72.3	280.5	818.8	225.8
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-41.8%	-8.5%	16.2	6.3	92.7	82.1	12.1	25.3	65.6	69.5	72.3	280.5	817.8

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-34.1%

3Y CAGR

4.7%

5Y CAGR

-0.4%

7Y CAGR

31.9%

10Y CAGR

12.8%

Cash from Operating Activity Annual is falling faster than historical averages.

Strides Pharma investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Documents

41.20% Gain from 52W Low

Strides Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Strides Pharma - Forecaster

Forecaster Analyst Estimates for Strides Pharma share price target, revenues, EPS, net income and more